Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Immuneering Corp (IMRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "Immuneering Reports Second Quarter 2023 Financial Results and Provides Business Updates"
05/05/2023 SC 13G/A BlackRock Inc. reports a 4.6% stake in Immuneering Corp
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
05/01/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/01/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/24/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
04/19/2023 8-K Quarterly results
04/19/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
04/18/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
04/18/2023 8-K Quarterly results
03/06/2023 10-K Annual Report for the period ended December 31, 2022
03/06/2023 8-K Investor presentation, Quarterly results
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 8.7% stake in Immuneering Corporation
02/14/2023 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 13.7% stake in IMMUNEERING CORP - CLASS A
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/08/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/10/2022 8-K Quarterly results
09/19/2022 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/22/2022 EFFECT Form EFFECT - Notice of Effectiveness:
08/10/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/10/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/10/2022 8-K Quarterly results
07/25/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Letter Agreement, by and between Immuneering Corporation and Mallory Morales"
06/24/2022 8-K Quarterly results
05/10/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/10/2022 8-K Quarterly results
05/02/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/02/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/10/2022 10-K Annual Report for the period ended December 31, 2021
03/10/2022 8-K Quarterly results
02/14/2022 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 12.2% stake in Immuneering Corp
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy